All questions
Indication: Repatha (evolocumab) in cardiovascular event risk reduction
1 question · 1 source
Indication questions that apply to every indication of Repatha are on Repatha (evolocumab), all indications: Indication.
Indication
What is Repatha approved for in cardiovascular risk reduction?
Note: The indication statement on the Repatha HCP site, as captured on November 13, 2026, omits "or any ischemia-driven arterial revascularization", which the Prescribing Information revised 10/2026 includes; the Prescribing Information is quoted here.